Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-03T00:59:01.118Z Has data issue: false hasContentIssue false

Alois Alzheimer Award

Published online by Cambridge University Press:  02 January 2018

Rights & Permissions [Opens in a new window]

Abstract

Type
Miscellany
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2000, The Royal College of Psychiatrists

Novartis Pharma Germany sponsors the Alois Alzheimer Award (AAA) for outstanding achievements in the research of Alzheimer's disease and/or other neurodegenerative disorders. The research of the future award-winner should have led to new insights into the aetiology, pathology, diagnosis or treatment of Alzheimer's disease. The AAA is endowed with US$20 000 — applications or proposals for nominations (eight copies) should be directed to the Secretary of the Jury Board, Professor Dr H. J. Molle, Chairman of the University Hospital of Psychiatry, Nussbaumstrasse 7, 80336 Munich, Germany. Please include a short curriculum vitae and reprints of up to three relevant papers.

The deadline for applications/nominations is 31 December 2000. The Jury Board consists of: Professor K. Beyreuther, Heidelberg; Professor C. G. Gottfries, Göteborg; Professor S. Henn, Mannheim; Professor R. Levey, London; Professor Dr J. M. Orgogozo, Bordeaux; Professor K. Maurer; Professor H. I. Moller; and Professor Dr B. Winblad, Huddinge.

Submit a response

eLetters

No eLetters have been published for this article.